title: Chemical modification and site-directed mutagenesis of the single cysteine in motif 3 of class II Escherichia coli prolyl-tRNA synthetase.
abstract: Class II prolyl-tRNA synthetase (ProRS) from Escherichia coli contains all three of the conserved consensus motifs characteristic of class II aminoacyl-tRNA synthetases. In this study, chemical modification and site-directed mutagenesis of the single cysteine located at position 443 in motif 3 of Escherichia coli ProRS is carried out. We show that chemical modification of C443 blocks the ability of the enzyme to form the activated aminoacyl-adenylate, a prerequisite for tRNA(Pro) aminoacylation. Nearly complete protection from inactivation is achieved by preincubating the enzyme with ATP or ATP and proline, but not proline alone or tRNA(Pro). Mutagenesis of C443 to amino acids Ala, Gly, and Ser resulted in significant decreases (16-225-fold) in k(cat)/K(M)(Pro) as measured by the ATP-PP(i) exchange reaction. The Ala and Gly mutations have a relatively small effect (4-7-fold) on the overall aminoacylation reaction, while the activity of the C443S mutant in this same assay is substantially reduced (80-fold). A sequence comparison of the motif 3 region of class II synthetases shows that C443 aligns with residues that have been implicated in amino acid binding specificity. The results of our study suggest that while the thiol located at position 443 of Escherichia coli ProRS is not essential for catalysis, this residue is likely to be in a buried region that forms the prolyl-adenylate substrate binding pocket.
authors.affiliation: Department of Chemistry, University of Minnesota, Minneapolis 55455, USA.
authors.forename: C
authors.initials: C
authors.lastname: Stehlin
authors.forename: D H
authors.initials: DH
authors.lastname: Heacock
authors.forename: H
authors.initials: H
authors.lastname: Liu
authors.forename: K
authors.initials: K
authors.lastname: Musier-Forsyth
mesh_terms: D000595:Amino Acid Sequence; D000604:Amino Acyl-tRNA Synthetases / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D001665:Binding Sites; D002384:Catalysis; D003545:Cysteine / Q000737:chemistry / Q000235:genetics; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004926:Escherichia coli / Q000201:enzymology*; D007460:Iodoacetamide / Q000494:pharmacology; D007700:Kinetics; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D009282:Naphthalenesulfonates / Q000494:pharmacology; D017354:Point Mutation; D012346:RNA, Transfer, Amino Acyl / Q000096:biosynthesis*; D016415:Sequence Alignment
chemical_list: D004791:Enzyme Inhibitors; D009282:Naphthalenesulfonates; D012346:RNA, Transfer, Amino Acyl; D004228:Dithionitrobenzoic Acid; D000604:Amino Acyl-tRNA Synthetases; C100134:prolyl T RNA synthetase; D003545:Cysteine; D007460:Iodoacetamide